<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26889">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02756689</url>
  </required_header>
  <id_info>
    <org_study_id>F151022005</org_study_id>
    <nct_id>NCT02756689</nct_id>
  </id_info>
  <brief_title>Outpatient Foley For Starting Induction of Labor at TErm</brief_title>
  <acronym>OFFSITE</acronym>
  <official_title>Outpatient Foley for Starting Induction of Labor at Term</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are performing a randomized controlled-trial investigating starting
      cervical ripening in the outpatient setting with a mechanical method, the transcervical
      Foley catheter. This is a pilot study to establish the efficacy of this method in decreasing
      time as in inpatient and evaluate patient satisfaction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Induction of labor is necessary in one-fourth of women and a large proportion requires
      cervical ripening. Cervical ripening is necessary to shorten the time to delivery and
      increases the chances of a vaginal delivery.

      Outpatient cervical ripening is an attractive alternative to women and physicians because of
      the decreased amount of time spent in the hospital and opportunity for patients to be in the
      comforts of their home.

      The investigators will conduct a randomized controlled trial comparing outpatient to
      inpatient cervical ripening using a transcervical Foley catheter. Women will be randomized
      to undergo inpatient or outpatient transcervical Foley catheter cervical ripening beyond
      their 39th week of gestation. Women and their infants will be followed until the time of
      their discharge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total time from admission to delivery</measure>
    <time_frame>From the time of admission until delivery, assessed up to 3 days.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Postpartum inpatient time period (up to 5 days after delivery)</time_frame>
    <description>Questionnaires, Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Placental abruption</measure>
    <time_frame>From the time of Foley catheter placement until delivery, assessed up to 3 days after placement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early admission for intractable pain (outpatient group)</measure>
    <time_frame>From the time of Foley placement until admission, up to 12 hours after placement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-reassuring fetal heart tracing upon scheduled admission</measure>
    <time_frame>From the time of Foley placement until admission, up to 12 hours after placement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-reassuring fetal heart rate tracing while the transcervical catheter remains in place requiring immediate delivery</measure>
    <time_frame>From the time of Foley placement until it comes out, up to 24 hours after placement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intractable pain requiring epidural anesthesia while the transcervical catheter remains in situ</measure>
    <time_frame>From the time of Foley placement until it comes out, up to 24 hours after placement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Labor and delivery emergency department (i.e. triage) visits prior to scheduled admission time (outpatient group)</measure>
    <time_frame>From the time of Foley placement until admission, up to 12 hours after placement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous rupture of membranes occurring in the outpatient group prior to scheduled admission time</measure>
    <time_frame>From the time of Foley placement until admission, up to 12 hours after placement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chorioamnionitis or endometritis</measure>
    <time_frame>From the time of transcervical Foley placement until delivery, assessed up to 6 days after placement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total time of epidural use</measure>
    <time_frame>From the time of epidural placement until delivery, assessed up to 3 days after placement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mode of delivery</measure>
    <time_frame>From the time of admission until delivery, assessed up to 3 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total time of oxytocin infusion</measure>
    <time_frame>From the time of admission until delivery, assessed up to 3 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cumulative dose of oxytocin infused</measure>
    <time_frame>From the time of admission until delivery, assessed up to 3 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum rate (milliunits/min) of oxytocin infused</measure>
    <time_frame>From the time of admission until delivery, assessed up to 3 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Labor and delivery charges</measure>
    <time_frame>From the time of admission until delivery, assessed up to 3 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite neonatal outcomes</measure>
    <time_frame>From the time of delivery to neonatal discharge, assessed up to 90 days.</time_frame>
    <description>The composite will include Apgar score &lt; 7 at 5 minutes, arterial cord blood gas pH &lt; 7.1, arterial cord blood gas base deficit &gt; 12, and admission to the neonatal intensive care unit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Inpatient Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm will be seen in the outpatient setting, and if they qualify and are randomized to the inpatient (control) group, they will be admitted to labor and delivery the next day for cervical ripening with a transcervical Foley catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Outpatient Group (Intervention)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm will undergo cervical ripening with a transcervical Foley catheter in the outpatient setting (treatment arm). The transcervical catheter will be placed in the office after confirmation of fetal well-being. They will then return the next morning to be admitted to labor and delivery for oxytocin administration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inpatient cervical ripening</intervention_name>
    <description>Subjects will undergo cervical ripening in the inpatient setting.</description>
    <arm_group_label>Inpatient Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Outpatient cervical ripening</intervention_name>
    <description>Subjects will undergo cervical ripening in the outpatient setting. The patients will then be scheduled to return the next morning for induction of labor.</description>
    <arm_group_label>Outpatient Group (Intervention)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18

          -  Multiparous

          -  Singleton gestation

          -  Gestational age between 39+0 and 42+0

          -  Vertex presentation

          -  Cervix ≤ 3 cm. If cervix is between 2 and 3 cm dilated, it must be &lt;80% effaced

          -  No prior cesarean section or uterine surgery

          -  Resides within Jefferson County, Alabama.

          -  Access to a telephone

          -  Reliable transportation

        Exclusion Criteria:

          -  Unsuitable for outpatient Foley placement management (IUGR, oligohydramnios, prior
             cesarean delivery, gestational hypertension, preeclampsia, or uncontrolled chronic
             hypertension, complex maternal disease, provider discretion). Any patient with
             pregestational or gestational diabetes on medications will be excluded.

          -  Latex allergy

          -  Contraindication to induction of labor

          -  Evidence of labor

          -  Fetal anomaly or demise

          -  Inability to given consent (non-English speaking, inability to read or write)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Spencer G Kuper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UAB, Division of Obstetrics and Gynecology, Department of Maternal-Fetal Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Spencer G Kuper, MD</last_name>
    <phone>205-934-9188</phone>
    <email>sgkuper@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lorie M Harper, MD, MSCI</last_name>
    <phone>205-934-2565</phone>
    <email>lmharper@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Spencer G Kuper, MD</last_name>
      <phone>205-934-9188</phone>
      <email>sgkuper@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Spencer G Kuper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorie M Harper, MD, MSCI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>WHO Recommendations for Induction of Labour. Geneva: World Health Organization; 2011.</citation>
    <PMID>23586118</PMID>
  </reference>
  <reference>
    <citation>Kelly AJ, Alfirevic Z, Ghosh A. Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database Syst Rev. 2013 Nov 12;(11):CD007372. doi: 10.1002/14651858.CD007372.pub3. Review.</citation>
    <PMID>24222365</PMID>
  </reference>
  <reference>
    <citation>Wing DA. Labor induction with misoprostol. Am J Obstet Gynecol. 1999 Aug;181(2):339-45. Review.</citation>
    <PMID>10454679</PMID>
  </reference>
  <reference>
    <citation>Alfirevic Z, Kelly AJ, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD003246. doi: 10.1002/14651858.CD003246.pub2. Review.</citation>
    <PMID>19821304</PMID>
  </reference>
  <reference>
    <citation>Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BW, Irion O, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001233. doi: 10.1002/14651858.CD001233.pub2. Review.</citation>
    <PMID>22419277</PMID>
  </reference>
  <reference>
    <citation>Farmer KC, Schwartz WJ 3rd, Rayburn WF, Turnbull G. A cost-minimization analysis of intracervical prostaglandin E2 for cervical ripening in an outpatient versus inpatient setting. Clin Ther. 1996 Jul-Aug;18(4):747-56; discussion 702.</citation>
    <PMID>8879901</PMID>
  </reference>
  <reference>
    <citation>Dowswell T, Kelly AJ, Livio S, Norman JE, Alfirevic Z. Different methods for the induction of labour in outpatient settings. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007701. doi: 10.1002/14651858.CD007701.pub2. Review.</citation>
    <PMID>20687092</PMID>
  </reference>
  <reference>
    <citation>O'Brien JM, Mercer BM, Cleary NT, Sibai BM. Efficacy of outpatient induction with low-dose intravaginal prostaglandin E2: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1995 Dec;173(6):1855-9.</citation>
    <PMID>8610775</PMID>
  </reference>
  <reference>
    <citation>McKenna DS, Costa SW, Samuels P. Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstet Gynecol. 1999 Jul;94(1):11-4.</citation>
    <PMID>10389710</PMID>
  </reference>
  <reference>
    <citation>ACOG Committee on Practice Bulletins -- Obstetrics.. ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-97. doi: 10.1097/AOG.0b013e3181b48ef5. Review.</citation>
    <PMID>19623003</PMID>
  </reference>
  <reference>
    <citation>Edwards RK, Szychowski JM, Berger JL, Petersen M, Ingersoll M, Bodea-Braescu AV, Lin MG. Foley catheter compared with the controlled-release dinoprostone insert: a randomized controlled trial. Obstet Gynecol. 2014 Jun;123(6):1280-7. doi: 10.1097/AOG.0000000000000238.</citation>
    <PMID>24807327</PMID>
  </reference>
  <reference>
    <citation>Pettker CM, Pocock SB, Smok DP, Lee SM, Devine PC. Transcervical Foley catheter with and without oxytocin for cervical ripening: a randomized controlled trial. Obstet Gynecol. 2008 Jun;111(6):1320-6. doi: 10.1097/AOG.0b013e31817615a0.</citation>
    <PMID>18515515</PMID>
  </reference>
  <reference>
    <citation>Sciscione AC, Bedder CL, Hoffman MK, Ruhstaller K, Shlossman PA. The timing of adverse events with Foley catheter preinduction cervical ripening; implications for outpatient use. Am J Perinatol. 2014 Oct;31(9):781-6. doi: 10.1055/s-0033-1359718. Epub 2013 Dec 17.</citation>
    <PMID>24347259</PMID>
  </reference>
  <reference>
    <citation>Henry A, Madan A, Reid R, Tracy SK, Austin K, Welsh A, Challis D. Outpatient Foley catheter versus inpatient prostaglandin E2 gel for induction of labour: a randomised trial. BMC Pregnancy Childbirth. 2013 Jan 29;13:25. doi: 10.1186/1471-2393-13-25.</citation>
    <PMID>23356673</PMID>
  </reference>
  <reference>
    <citation>McMaster K, Sanchez-Ramos L, Kaunitz AM. Evaluation of a Transcervical Foley Catheter as a Source of Infection: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015 Sep;126(3):539-51. doi: 10.1097/AOG.0000000000001002. Review.</citation>
    <PMID>26244535</PMID>
  </reference>
  <results_reference>
    <citation>Sciscione AC, Muench M, Pollock M, Jenkins TM, Tildon-Burton J, Colmorgen GH. Transcervical Foley catheter for preinduction cervical ripening in an outpatient versus inpatient setting. Obstet Gynecol. 2001 Nov;98(5 Pt 1):751-6.</citation>
    <PMID>11704164</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 6, 2017</lastchanged_date>
  <firstreceived_date>April 11, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Spencer G. Kuper</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Mechanical cervical ripening</keyword>
  <keyword>Transcervical catheter</keyword>
  <keyword>Foley catheter for labor induction</keyword>
  <keyword>Cervical ripening</keyword>
  <keyword>Induction of labor</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
